Of the 28 patients,16 achieved CR,and 8 patients achieved PR,with a total response rate 85.7%. 1?year survival rate was 60.7%(17/28).

• 肿瘤病灶完全缓解(CR)16例(57.；1%25)；部分缓解(PR)8例(28